Sign in

CIK 0000875320

  • Large accelerated filer

VERTEX PHARMACEUTICALS INC / MA

Sign in to watch
Ticker
VRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
Operating
EIN
043039129
Phone
+1 617-341-6393
Business address
50 NORTHERN AVENUE, BOSTON, MA, 02210
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,378,206
in 4 filings, $15.4M under 10b5-1 plans

Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-13 Arbuckle Stuart A EVP, COO Exercise or conversion 10b5-1 +8,603 $187.53 $1.6M 65,159
2023-12-13 Arbuckle Stuart A EVP, COO Sale 10b5-1 −8,603 $399.00 $3.4M 56,556
2023-12-13 Arbuckle Stuart A EVP, COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −8,603 0
2023-12-05 Thornberry Nancy Director Grant or award +1,136 1,136

Page 27 of 27 · 524 trades